The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives
DOI:
https://doi.org/10.14739/2409-2932.2014.2.26165Keywords:
Pharmacological Actions, Drug Screening, Animal Experimental, Toxic Hepatitis, 1, 2, 4-triazoleAbstract
Aim. The search of new high-effective drugs is an actual problem of modern science. The purpose of our research was the pharmacological screening of 1,2,4-triazoles derivatives. Experiments have been performed on adult Wistar white rats.
Methods and results. Compounds have been entered in a 1/10 dose of LD50, which have been determined before performing experiments. The article presents hepatoprotective activity of new synthesized compounds in simulated acute liver injury. We present a comparison with reference drugs in the experiment.
Сonclusion. Screening has shown that these class of compounds is promising for further research.
References
Stefanov, O. V. (Ed.) (2001) Doklinichni doslidzhenia likarskikh zakhodiv [Preclinic investigation medicines]. Kyiv: Avicena. [in Ukrainian].
Morozov, S. Yu. (2009) Gepatoprotektory v praktike vracha-klinicista [Hepatoprotectors in practic work of clinic doctor]. Russkij medicinskij zhurnal, 11(1), 25. [in Russian].
Polunina, T. E., Maev, I. V., & Polunina, E. V. (2009) Hepatologiya dlya practicheskogo vracha [Hepatology for practic doctor]. Moscow: Avtorskaya academiya. [in Russian].
Prozorovskii, V. B. (2007) Statisticheskaya obrabotka rezul'tatov farmakologicheskikh issledovanij [Statistic processing of data of pharmacological investigations]. Psikhofarmakologiya i biologicheskaya narkologiya, 7(3-4), 2090–2120. [in Russian].
Tkach, S. M. (2009) [Effectiveness and safety hepatoprotectors terms of evidence-based medicine]. Zdorov`e Ukrainy, 6, 7–10. [inUkrainian].
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non–alcoholic fatty liver disease. J Clin Invest, 115(5), 1343–1351.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
